These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25546784)

  • 1. 7th International Immunoglobulin Conference: Immunomodulation.
    Danieli MG; Shoenfeld Y
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):112-4. PubMed ID: 25546784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7th International Immunoglobulin Conference: Immunomodulation.
    Danieli MG; Shoenfeld Y
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):123. PubMed ID: 25546788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.
    Czernik A; Bystryn JC
    Arch Dermatol; 2008 May; 144(5):658-61. PubMed ID: 18490594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
    Hashimoto T; Ishii N; Ohata C; Furumura M
    J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
    Rütter A; Luger TA
    J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern diagnosis of autoimmune blistering skin diseases.
    Schmidt E; Zillikens D
    Autoimmun Rev; 2010 Dec; 10(2):84-9. PubMed ID: 20713186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris.
    Arnold DF; Burton J; Shine B; Wojnarowska F; Misbah SA
    Br J Dermatol; 2009 May; 160(5):1098-102. PubMed ID: 19222460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases.
    Blank M; Bashi T; Shoenfeld Y
    Methods Mol Biol; 2014; 1060():353-61. PubMed ID: 24037850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mechanism for therapeutic action of IVIg in autoimmune blistering dermatoses.
    Michael D; Grando SA
    Curr Dir Autoimmun; 2008; 10():333-43. PubMed ID: 18460894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
    Mouthon L; Kaveri S; Kazatchkine M
    Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
    Hurez V; Kaveri SV; Kazatchkine MD
    J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.
    Czernik A; Toosi S; Bystryn JC; Grando SA
    Autoimmunity; 2012 Feb; 45(1):111-8. PubMed ID: 21923613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin and autoimmune disease.
    El-Shanawany T; Jolles S
    Ann N Y Acad Sci; 2007 Sep; 1110():507-15. PubMed ID: 17911466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg?
    Lamoureux J; Aubin E; Lemieux R
    Int Immunol; 2004 Jul; 16(7):929-36. PubMed ID: 15159376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation with intravenous immunoglobulin.
    Hall PD
    Pharmacotherapy; 1993; 13(6):564-73. PubMed ID: 8302679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.